Quick Takeaways
- DIMENSIONAL FUND ADVISORS LP filed SCHEDULE 13G for Castle Biosciences Inc Common Stock (CSTL).
- Disclosed ownership: 5.1%.
- Date of event: 30 Sep 2025.
DIMENSIONAL FUND ADVISORS LP - 30 Sep 2025 SCHEDULE 13G Report for Castle Biosciences Inc Common Stock (CSTL)
- Filing Manager
- DIMENSIONAL FUND ADVISORS LP
- Reporting Manager
- Dimensional Fund Advisors LP
- Security
- Castle Biosciences Inc Common Stock
- Symbol
- CSTL
- Shares outstanding
- 28,903,706 shares
- Disclosed Ownership
- 1,474,089 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Oct 2025, 13:48:12 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 21 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"DIMENSIONAL FUND ADVISORS LP disclosed 5.1% ownership in Castle Biosciences Inc Common Stock (CSTL) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Oct 2025, 13:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 5.1% | 1,474,089 | 1,447,712 | 0 | Selwyn Notelovitz | Global Chief Compliance Officer |